Dr. Christine Edwards -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Christine Edwards, a Hepatology physician based in Flint, MI. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Christine Edwards has received $101.48 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Christine Edwards
- Medical Specialty: Hepatology
- Practice Location: Flint, MI, Michigan
- NPI Number: 1038816905
- Transparency Score: 50/100
- Payment Records Span: 2024-06-14 to 2024-06-14
Payment Summary
Dr. Christine Edwards has received a total of $101.48 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $101.48 per transaction.
- Total Payments Received: $101.48
- Number of Transactions: 1
- Average Payment: $101.48
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Hepatology. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
- Drugs/Devices Referenced: 1 distinct products
Payment Breakdown by Category
The following table shows how Dr. Christine Edwards's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Food & Beverage | $101.48 | Meals and refreshments during sales visits, meetings, and events |
The largest payment category for Dr. Christine Edwards is Food & Beverage, accounting for 100% ($101.48) of total pharmaceutical payments received. This is the most common type of pharmaceutical payment and typically involves meals provided during sales representative visits.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Christine Edwards. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Gilead Sciences | $101.48 | 1 |
Dr. Christine Edwards has a financial relationship with Gilead Sciences, receiving $101.48 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
Drugs and Medical Devices Referenced in Payments
The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Christine Edwards. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.
- Xarelto -- Referenced in payment records from pharmaceutical companies to Dr. Christine Edwards
The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Christine Edwards's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Christine Edwards has received $101.48 across 1 pharmaceutical payments as a Hepatology physician in Flint, MI. Top paying companies include Gilead Sciences ($101.48). Dr. Edwards received a single payment of $101 in 2024. This payment was from Gilead Sciences, a major pharmaceutical company. The payment was categorized as a 'meal'.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Christine Edwards is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
Patients may wish to inquire about any potential conflicts of interest or how pharmaceutical interactions might influence treatment recommendations, though Dr. Edwards' profile suggests limited such interactions. Always feel free to ask your doctor directly about their pharmaceutical relationships.
Peer Comparison: How Dr. Christine Edwards Compares to Other Hepatology Physicians
As a Hepatology specialist, Dr. Edwards' payment profile is minimal compared to peers who may engage more frequently with pharmaceutical companies for research, speaking engagements, or consulting.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Christine Edwards in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Gilead Sciences | $101.48 | meals | Xarelto | 2024-06-14 | Not Assessed |
Frequently Asked Questions About Dr. Christine Edwards's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
How much pharma money has Christine Edwards received?
Christine Edwards has received a total of $101.48 across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.
Is Christine Edwards taking too much pharma money?
Christine Edwards has received $101.48 in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Hepatology), the types of payments, and how they compare to peers. The largest payment category is meals ($101.48). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.
What pharma companies pay Christine Edwards?
The top pharmaceutical companies paying Christine Edwards are: Gilead Sciences ($101.48). These payments cover various categories including consulting, meals, speaking fees, and research grants.
What kinds of payments does Christine Edwards receive?
Christine Edwards's payments by type: meals: $101.48. Food and beverage is the most common payment type across all physicians.
Should I switch doctors because of pharma payments?
Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.
How do Christine Edwards's payments compare to other Hepatology doctors?
To compare, look at the total amount ($101.48), number of payments (1), and the types of payments received. Hepatology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.
How can I verify Christine Edwards's payment data?
You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1038816905). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.
Do pharma payments affect prescribing quality?
Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.
What stands out about Christine Edwards's pharma payment profile?
The doctor's payment profile is very limited, with only one recorded transaction. Christine Edwards has received $101.48 in total pharma payments.
How does Christine Edwards compare to peers in Hepatology?
As a Hepatology specialist, Dr. Edwards' payment profile is minimal compared to peers who may engage more frequently with pharmaceutical companies for research, speaking engagements, or consulting.
Are Christine Edwards's pharma relationships typical for Hepatology?
The entire payment amount comes from a single company, indicating high company concentration.
What should patients of Christine Edwards know about these payments?
Patients may wish to inquire about any potential conflicts of interest or how pharmaceutical interactions might influence treatment recommendations, though Dr. Edwards' profile suggests limited such interactions.
What patterns are visible in Christine Edwards's payment history?
The payment is associated with a single drug, Xarelto.
Understanding This Doctor Payment Report
This transparency report for Dr. Christine Edwards is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Hepatology physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Christine Edwards's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Christine Edwards and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- Hepatology Specialty Payment Data -- See payment patterns for all hepatology physicians
- Michigan Physician Payments -- Browse pharmaceutical payments to physicians in Michigan
- Hepatology Physicians in Michigan -- Compare Dr. Christine Edwards to peers in the same state and specialty
- Gilead Sciences Payment Profile -- View all payments made by Dr. Christine Edwards's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Christine Edwards's NPI (1038816905) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.